当前位置:首页 - 行情中心 - 科源制药(301281) - 财务分析

科源制药

(301281)

  

流通市值:23.13亿  总市值:36.39亿
流通股本:6885.20万   总股本:1.08亿

科源制药(301281)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.43亿元,每股收益0.39元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益138210.25万元,未分配利润31107.87万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产160434.56万元,负债22224.31万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入227,866,001.27111,204,722.41463,716,804.91330,879,995.68
营业总成本191,517,077.8493,014,492.94415,074,066.11303,707,035.89
其他经营收益
营业利润39,127,935.320,049,800.0468,262,611.8745,779,440.84
利润总额43,765,022.7223,647,716.4665,708,514.6742,917,141.46
净利润42,641,961.623,067,656.4860,271,862.2539,555,461.09
每股收益
其他综合收益----
综合收益总额42,641,961.623,067,656.4860,271,862.2539,555,461.09
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计655,916,046.11680,167,116.36690,734,868.56643,859,810.97
非流动资产:
非流动资产合计948,429,558.82895,845,377.25861,739,402.58820,808,350.76
资产总计1,604,345,604.931,576,012,493.611,552,474,271.141,464,668,161.73
流动负债:
流动负债合计100,067,523.62102,712,817.61119,784,825.8599,136,243.47
非流动负债:
非流动负债合计122,175,539.5490,055,224.6673,085,908.628,054,190.26
负债合计222,243,063.16192,768,042.27192,870,734.45127,190,433.73
所有者权益(或股东权益):
归属于母公司股东权益合计1,381,335,721.41,382,453,759.441,358,795,634.771,336,620,591.67
股东权益合计1,382,102,541.771,383,244,451.341,359,603,536.691,337,477,728
负债和股东权益合计1,604,345,604.931,576,012,493.611,552,474,271.141,464,668,161.73
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计151,884,597.7980,531,337.43367,204,068.33271,653,032.95
经营活动现金流出小计126,314,818.2881,083,486.09427,719,852.28247,782,116.39
经营活动产生的现金流量净额25,569,779.51-552,148.66-60,515,783.9523,870,916.56
投资活动产生的现金流量:
投资活动现金流入小计444,908,865.5179,091,865.86970,622,262.23861,878,324.86
投资活动现金流出小计383,244,915.81215,886,268.131,158,200,062.05911,548,188.84
投资活动产生的现金流量净额61,663,949.69-36,794,402.27-187,577,799.82-49,669,863.98
筹资活动产生的现金流量:
筹资活动现金流入小计53,617,376.0821,005,121.4347,631,955.61,000,000
筹资活动现金流出小计25,142,879.525,558,296.732,562,968.6632,487,820.72
筹资活动产生的现金流量净额28,474,496.5615,446,824.7315,068,986.94-31,487,820.72
汇率变动对现金及现金等价物的影响513,591.9415,142.81585,250.5381,826.89
现金及现金等价物净增加额116,221,817.66-21,484,583.39-232,439,346.33-56,904,941.25
期末现金及现金等价物余额207,991,585.8770,257,798.5291,769,768.21267,304,173.29
补充资料:
现金及现金等价物的净增加额116,221,817.66--232,439,346.33-
最新报告期:2025-08-18
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
东莞证券谢雄雄0.650.730.752025-08-18
TOP↑